Short Interest in XOMA Co. (NASDAQ:XOMAO) Drops By 89.8%

XOMA Co. (NASDAQ:XOMAO) saw a large drop in short interest in April. As of April 30th, there was short interest totaling 290 shares, a drop of 89.8% from the April 15th total of 2,830 shares. Based on an average daily volume of 8,328 shares, the short-interest ratio is currently 0.0 days.

XOMA Stock Up 0.0%

Shares of XOMAO stock traded up $0.01 on Wednesday, hitting $25.24. The company’s stock had a trading volume of 1,328 shares, compared to its average volume of 3,953. XOMA has a fifty-two week low of $24.86 and a fifty-two week high of $26.40. The firm’s fifty day moving average price is $25.48 and its 200-day moving average price is $25.43.

XOMA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd were given a dividend of $0.5234 per share. The ex-dividend date of this dividend was Thursday, April 2nd. This represents a $2.09 dividend on an annualized basis and a yield of 8.3%.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.